Abvance Therapeutics, a biotechnology company developing next generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the presentation of new ...

Endogenex today reported positive findings from studies of its endoscopic procedure aimed at transforming diabetes care.

Results were presented at the 2025 American College of Veterinary Internal Medicine (ACVIM) Forum in Louisville, Kentucky.

Medscape Education is proud to present 11 publications at the American Diabetes Association 85th Scientific Sessions, taking place June 20–23 in Chicago.

New study examines benefits of continuous glucose monitoring (CGM) in people with type 2 diabetes (T2D) using glucagon-like ...

muscle-preserving weight loss drug candidate ASC47 will be presented at the 85th Scientific Sessions of American Diabetes Association (ADA) in Chicago, U.S. Details of the Poster Presentations Poster ...

DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and type 2 diabetes (T2D). Agonism of GPR119 in ...

DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and type 2 diabetes (T2D). Agonism of ...